Chargement de la fiche…
Chargement de la fiche…
rhumatologie
Hospitalo-universitaire
Bordeaux (33076)
Rheumatoid Arthritis Research and Therapies · Spondyloarthritis Studies and Treatments · Systemic Lupus Erythematosus Research
Tout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
2004–2026
Centre Hospitalier Universitaire de Bordeaux
2011–2024
Université de Bordeaux
2024
Université de Lille
2015–2023
Centre National de la Recherche Scientifique
2018
Sciences Po Bordeaux
2018
Inserm
0
h-index
0
i10
0
citations
Le h-index mesure la productivité scientifique : ce médecin a publié 60 articles cités au moins 60fois par d'autres chercheurs. Plus c'est élevé, plus son travail influence la communauté médicale.
Côté patient
Comprendre votre pathologie, exercices à domicile, applications validées, paramédicaux à proximité — gratuit, sans inscription.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'Études Spécialisées
DE Docteur en médecine — Capacité / Certificat d'Études Spéciales
0
travaux
0
h-index
0
i10-index
0
citations
2025Joint bone spine
PubMed ↗Resolution of immune checkpoint inhibitors-induced inflammatory arthritis while maintaining active treatment with checkpoint inhibitors and after its discontinuation: An observational study
2025The European respiratory journal
PubMed ↗Short telomere length is associated with accelerated lung disease progression in rheumatoid arthritis-associated interstitial lung disease
2023RMD open
PubMed ↗Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study
2023Joint bone spine
PubMed ↗Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study
2023Lancet (London, England)
PubMed ↗FRENCH-ARRIVE: a serious, evidence-free, and false accusation of unethical research
2023Annals of the rheumatic diseases
PubMed ↗Correspondence on 'Factors associated with progression to inflammatory arthritis in first-degree relatives of individuals with RA following autoantibody positive screening in a non-clinical setting'
2022RMD open
PubMed ↗Use of a bDMARD or tsDMARD for the management of inflammatory arthritis under checkpoint inhibitors: an observational study
2022Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Interleukin-1β-Activated Microvascular Endothelial Cells Promote DC-SIGN-Positive Alternatively Activated Macrophages as a Mechanism of Skin Fibrosis in Systemic Sclerosis
2021Annals of the rheumatic diseases
PubMed ↗TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis
2021Rheumatology (Oxford, England)
PubMed ↗Cut-off value to identify a flare using the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire: analysis of the TOSCA study
2021European journal of cancer (Oxford, England : 1990)
PubMed ↗Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events
2021Journal of biomedical informatics
PubMed ↗Automatic phenotyping of electronical health record: PheVis algorithm
2021Revue du rhumatisme (Ed. francaise : 1993)
PubMed ↗Prise en charge des patients atteints de maladies rhumatismales pendant la pandémie de COVID-19 : la Société française de rhumatologie répond aux questions fréquentes posées jusqu’en mai 2020
2021Seminars in arthritis and rheumatism
PubMed ↗Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments
2021Rheumatology (Oxford, England)
PubMed ↗Role of stress in the development of rheumatoid arthritis: a case-control study
2021Rheumatology (Oxford, England)
PubMed ↗Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort
2021Seminars in arthritis and rheumatism
PubMed ↗MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression
2021Rheumatology (Oxford, England)
PubMed ↗Rapidly progressive interstitial lung disease under FOLFOX treatment for colorectal cancer associated with systemic sclerosis: two case reports
2021Annals of the rheumatic diseases
PubMed ↗EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
2020Rheumatology (Oxford, England)
PubMed ↗A simplified radiographic score effectively predicts radiographic progression of early arthritis in a large nationwide French cohort
2020The Journal of rheumatology
PubMed ↗Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA
2020Joint bone spine
PubMed ↗Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases
2020Annals of the rheumatic diseases
PubMed ↗'To switch or not to switch': the missing piece in the puzzle of biosimilar literature?
2020Revue du rhumatisme (Ed. francaise : 1993)
PubMed ↗Implications du COVID-19 pour la prise en charge des rhumatismes inflammatoires chroniques
2020Autoimmunity reviews
PubMed ↗Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014
2020The Journal of investigative dermatology
PubMed ↗Decreased CCN3 in Systemic Sclerosis Endothelial Cells Contributes to Impaired Angiogenesis
2020Joint bone spine
PubMed ↗Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020
2024Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission
2024Rheumatology (Oxford, England)
PubMed ↗Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry
2022Rheumatology (Oxford, England)
PubMed ↗Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept
2022Joint bone spine
PubMed ↗Improvement in patient-reported outcomes in rheumatoid arthritis patients treated with sarilumab is independent of the cognition levels
2021The Journal of rheumatology
PubMed ↗Real-world Risk of Relapse of Giant Cell Arteritis Treated With Tocilizumab: A Retrospective Analysis of 43 Patients
2021Rheumatology (Oxford, England)
PubMed ↗Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA)
2020Rheumatology (Oxford, England)
PubMed ↗Role of good oral hygiene on clinical evolution of rheumatoid arthritis: a randomized study nested in the ESPOIR cohort
2020BMJ open
PubMed ↗GlutenSpA trial: protocol for a randomised double-blind placebo-controlled trial of the impact of a gluten-free diet on quality of life in patients with axial spondyloarthritis
2020Seminars in arthritis and rheumatism
PubMed ↗Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial
2023Rheumatology (Oxford, England)
PubMed ↗Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM
2020Annals of the rheumatic diseases
PubMed ↗Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)
2020The Journal of rheumatology
PubMed ↗Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort
2025Advances in therapy
PubMed ↗Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT)
2025Rheumatology (Oxford, England)
PubMed ↗Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
2022European journal of clinical pharmacology
PubMed ↗JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study
2024Rheumatology (Oxford, England)
PubMed ↗Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry
2023Joint bone spine
PubMed ↗Treatment patterns in patients with rheumatoid arthritis initiating a JAK inhibitor or a TNF inhibitor based on retail pharmacies drug-dispensing data
2021Science translational medicine
PubMed ↗Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis
2023Microbiology spectrum
PubMed ↗Effects of Lumacaftor-Ivacaftor on Airway Microbiota-Mycobiota and Inflammation in Patients with Cystic Fibrosis Appear To Be Linked to Pseudomonas aeruginosa Chronic Colonization
2025Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
PubMed ↗Oncogenic rickets diagnosed at age 8 and the risk of persistent rickets: a rare case of pediatric-onset tumor-induced osteomalacia
2020BMJ open
PubMed ↗GlutenSpA trial: protocol for a randomised double-blind placebo-controlled trial of the impact of a gluten-free diet on quality of life in patients with axial spondyloarthritis
2022Rheumatology (Oxford, England)
PubMed ↗The response to TNF blockers depending on their comparator in rheumatoid arthritis clinical trials: the lessebo effect, a meta-analysis
2025Article
METHOFRACT, a methotrexate osteopathy multicentre cohort study
RMD Open : Rheumatic & Musculoskeletal Diseases
2024Article
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
Rheumatology
2024Article
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open‐Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission
Arthritis & rheumatology
2024Article
Towards the lowest efficacious dose (ToLEDo): results of a multicenter non‐inferiority randomized open‐label controlled trial assessing Tocilizumab or Abatacept injection spacing in rheumatoid arthritis in remission
Arthritis & rheumatology
2023Article
Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry
Rheumatology
2023Article
Effects of Lumacaftor-Ivacaftor on Airway Microbiota-Mycobiota and Inflammation in Patients with Cystic Fibrosis Appear To Be Linked to Pseudomonas aeruginosa Chronic Colonization
Microbiology Spectrum
2023Article
Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study
Joint Bone Spine
2022Article
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study
European Journal of Clinical Pharmacology
▶Histoire de la SFR et de la rhumatologie
Société Française de Rhumatologie
▶Les Journées Nationales de Rhumatologie 2025 aux côtés de Thierry Schaeverbeke
Société Française de Rhumatologie
▶Quelle place pour les thérapies complémentaires ?
AFPric
▶#01 « Le microbiote dans les rhumatismes inflammatoires » par le Pr Thierry SCHAEVERBEKE
Polyarthrite Andar
▶Thierry Schaeverbeke Séquence 02.wmv
Rhumatisme753
achat-logistique.info
Un ange gardien pour mieux suivre les maladies chroniques - achat-logistique.info
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOX1VFam5MbHZKS2owTlhVUVdBR3A5NWlzOUE0V1AyUjdURHhpNENjcUdHWFdFUFpGRFN0UmhNX21ERThTeUpGdjFtMlp5OEtSWVo3YXZyQnZVTnpJdFNNOUtqZ1dVU3BrakR5QzE1TmQ2Q0ZxOWRsbmswNzl4cVBwZ0ZjRjduZE1LVkpweU1NZ1d2WE1JTUZzY1RvaHN3Q1B4?oc=5" target="_blank">Un ange gar
Actu.fr
Maladies inflammatoires chroniques : Ange Gardien, l'application qui veille sur votre santé - Actu.fr
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNRVhSSlcta1dPZ0ZqWjAwaUxIRGpjWm1xQy1BWEhxWnFiazVMQ3k1QVhHQlptVGZBYU5uQm9ueEZ2OF9USFMtVW9HUDhTWVpiODVaM1R2SElQWWhlTE9XRXZCQlIwM1Y1SjdVb2QwNzFvN28yLUlxV1I4Q0YxeHBCdUtrM3JmRFl4OXpZNUtVZUJxOTBoNVd5M3pnYXk5Tk1JVDRvU2JlOTlFZmVUa3lqSkpMdFFNZw?oc=
Le Parisien
Mal de dos : et si c'était la faute d'une bactérie ? - Le Parisien
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOTWpmWFlWbGw2NnlrU1FGcy1jaWFuMjNDbC1PN0dyVlNSdmZIX09lX0x3ZU9HS19Mcmh1c0ZBai05X1VWYUpBOHBmQ2pONkVVZWJ2R0hLSWoyRTAtS3Q3TGtEdnppOGNnTjhwaU84U2pEeW5pRFcxNC0xQlZkRkt2SjVWUEJyZnJGWXViYi02QWpWWHdGWEl0V1gyQzdpRGxDdkk1RjBfczZHZw?oc=5" target="_blan
ladepeche.fr
Bagnères-de-Bigorre. Premières Journées de rhumatologie - ladepeche.fr
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxNM2cwSkxiNy14OFF1ejZGLV9iNm95NDlFUXoxQmNLQjM2Q0ROcnVHc2l6czU4RHZKYlhMSGttNzNKbHBQVjUyS0lpQkxlNmxPcU5TWEhzckxZbkxMWjFNTU5zZGpGWEx5djNIdmx6M200dEhFdzFNcUJpemJpbVRIUzE0WVZ5ZUFHRVowRmdBRkIwTHQxQVFEVmNZcnktLW1PNzBhZnh6d2JnX2VQRXJxYg?oc=5" targe
Encadrement de doctorants — signal d'activité universitaire.
2024Doctorant : Eloïse Ramel
Effet des inhibiteurs de la pompe à proton gastrique sur la réponse anti tumorale aux inhibiteurs de point de contrôle immunitaire
Bordeaux
2018Doctorant : Thomas Bazin
Microbiote intestinal et inflammation : prédiction de la réponse aux anti-TNFα dans les maladies inflammatoires chroniques et modulation de la croissance bactérienne in vitro en réponse au TNFα
Bordeaux
1995Doctorant : Laurence Lequen
Recherche systématique de mycoplasmes dans les sites extra-articulaires au cours de la polyarthrite rhumatoi͏̈de
Bordeaux 2
1995Doctorant : Janique Petit
Evolution au long cours du RS3PE (remitting seronegative symmetrical synovitis with pitting edema) : étude d'une série de neuf patients
Bordeaux 2
1995Doctorant : Paul Lamarque
Traitement des poussées de spondylarthropathies inflammatoires périphériques par les sels d'or : étude rétrospective d'une population de 50 patients
Bordeaux 2
1995Doctorant : Olivier Hallé
Sclérodermie et facteurs d'environnement : étude cas-témoins portant sur 51 sclérodermies et revue de la littérature
Bordeaux 2
Rhumatologues à proximité